← Back to Search

Bupivacaine for Local Anesthesia

Phase 2
Waitlist Available
Led By Nisha Lakhi, MD
Research Sponsored by Richmond University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All scheduled Cesarean deliveries with intrathecal or epidural anesthesia
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This study will investigate the effect of three types of wound infiltration on post Cesarean opioid analgesia consumption when used in conjunction with an opioid free postoperative analgesia pathway.

Eligible Conditions
  • Local Anesthesia
  • Opioid Use Disorder
  • Postoperative Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total number of opioid free Cesarean deliveries
Secondary outcome measures
Breast feeding capacity
Complications from procedures
Postoperative hospital stay
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Bupivacaine and DexmedetomidineExperimental Treatment2 Interventions
Wound Infiltration with 20 mL (150mg) of 0.75% bupivacaine and 1.5 mcg/kg of dexmedetomidine will be diluted with normal saline to make 25 mL of solution .
Group II: BupivacaineExperimental Treatment1 Intervention
Wound Infiltration with 20 mL (150mg) of 0.75% bupivacaine diluted with 5 mL of normal saline to give a 25 mL
Group III: PlaceboPlacebo Group1 Intervention
Wound infiltration with a placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Dexmedetomidine
FDA approved

Find a Location

Who is running the clinical trial?

Richmond University Medical CenterLead Sponsor
4 Previous Clinical Trials
1,382 Total Patients Enrolled
Nisha Lakhi, MDPrincipal InvestigatorRichmond University Medical Center
2 Previous Clinical Trials
1,282 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery
Nisha Lakhi, MD 2018. "Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03545516.
All > Opiate Addiction > Exparel
~82 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top